Terzis Julia K, Kokkalis Zinon T
Hand (N Y). 2010 Sep;5(3):326-37. doi: 10.1007/s11552-009-9253-0. Epub 2010 Apr 2.
The authors' experience with the supraclavicular approach for the treatment of patients with primary thoracic outlet syndrome (TOS) and for patients with recurrent TOS or iatrogenic brachial plexus injury after prior transaxillary first rib resection is presented. The records of 33 patients (34 plexuses) with TOS who presented for evaluation and treatment were analyzed. Of these, 12 (35%) plexuses underwent surgical treatment, and 22 (65%) plexuses were managed non-operatively. The patients who were treated non-operatively and had an adequate follow-up (n = 11) were used as a control group. Of the 12 surgically treated patients, five patients underwent primary surgery; four patients had secondary surgery for recurrent TOS; and three patients had surgery for iatrogenic brachial plexus injury. All patients presented with severe pain, and most of them had neurologic symptoms. All nine (100%) patients who underwent primary surgery (n = 5) and secondary surgery for recurrent TOS (n = 4) demonstrated excellent or good results. On the other hand, six (54%) of the 11 patients from the control group had some benefit from the non-operative treatment. Reoperation in three patients with iatrogenic brachial plexus injury resulted in good result in one case and in fair results in two patients; however, all patients were pain-free. No complications were encountered. Supraclavicular exploration of the brachial plexus enables precise assessment of the contents of the thoracic inlet area. It allows for safe identification and release of all abnormal anatomical structures and complete first rib resection with minimal risk to neurovascular structures. Additionally, this approach allows for the appropriate nerve reconstruction in cases of prior transaxillary iatrogenic plexus injury.
The online version of this article (doi:10.1007/s11552-009-9253-0) contains supplementary material, which is available to authorized users.
本文介绍了作者采用锁骨上入路治疗原发性胸廓出口综合征(TOS)患者,以及治疗复发性TOS患者或先前经腋路第一肋切除术后医源性臂丛神经损伤患者的经验。分析了33例因TOS前来评估和治疗的患者(34条臂丛神经)的记录。其中,12条(35%)臂丛神经接受了手术治疗,22条(65%)臂丛神经采用非手术治疗。将接受非手术治疗且随访充分的患者(n = 11)作为对照组。在12例接受手术治疗的患者中,5例患者接受了初次手术;4例患者因复发性TOS接受了二次手术;3例患者因医源性臂丛神经损伤接受了手术。所有患者均表现为严重疼痛,且大多数患者有神经症状。所有9例(100%)接受初次手术(n = 5)和复发性TOS二次手术(n = 4)的患者均显示出优或良的效果。另一方面,对照组的11例患者中有6例(54%)从非手术治疗中获得了一定益处。3例医源性臂丛神经损伤患者再次手术后,1例效果良好,2例效果尚可;然而,所有患者均无疼痛。未发生并发症。锁骨上入路探查臂丛神经能够精确评估胸廓入口区域的内容物。它允许安全地识别和松解所有异常解剖结构,并完整切除第一肋,对神经血管结构的风险最小。此外,对于先前经腋路医源性臂丛神经损伤的病例,这种入路允许进行适当的神经重建。
本文的在线版本(doi:10.1007/s11552-009-9253-0)包含补充材料,授权用户可获取。